We do that by being very transparent about our results each month ... World Pediatrics and the National Multiple Sclerosis Society. A quote I live by: My grandfather always told me, “No one can take ...

Abu Dhabi – The National Multiple Sclerosis Society (NMSS) has awarded AED 4 million in research grants to six UAE-based projects designed to accelerate progress in the understanding, diagnosis, and ...

ABU DHABI, 30th May 2025 (WAM) -- The National Multiple Sclerosis Society (NMSS) has signed a strategic agreement with Erth Zayed Philanthropies to advance its national multiple sclerosis (MS) agenda.

All proceeds will benefit the National Multiple Sclerosis Society, supporting its vital work in research, care, and education. Let’s row for resilience. Let’s row for change. Let’s Row for a ...

The National Multiple Sclerosis Society (NMSS) has signed a strategic agreement with Erth Zayed Philanthropies to advance its national multiple sclerosis (MS) agenda. As part of this agreement, Erth ...

Strategic collaboration to drive the UAE’s national MS agenda. Abu Dhabi – The National Multiple Sclerosis Society (NMSS) has signed a strategic agreement with Erth Zayed Philanthropies to advance its ...

People with multiple sclerosis (MS) often face higher unemployment rates. Understanding the challenges and available support can help you navigate employment and financial stability. Many people ...

The National Geographic Society — one of the world's largest and most influential science organizations — is going to pour money into the movement. From the National Geographic website ...

Presenting Author: Dr. John Foley – Rocky Mountain Multiple Sclerosis, Salt Lake City, Utah Following the presentations, the data presented will be available on the Publications page ...

NEW YORK, May 30, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentations of data highlighting BRIUMVI® (ublituximab-xiiy) in patients with relapsing ...

(MENAFN- GlobeNewsWire - Nasdaq) NEW YORK, May 30, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentations of data highlighting BRIUMVI® (ublituximab-xiiy ...